Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-28

Clinical Trial Update: A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate a sequential treatment of cryotherapy followed by Picato (ingenol mebutate) for actinic keratosis on the face and scalp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Picato (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-28